.the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid..jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies.. another new drug in the migraine pipeline is lasmiditan. it works the same way as triptans. but unlike the triptans, it doesn't constrict..